LT
Larimar Therapeutics Inc
🇺🇸XNAS.LRMRUnited StatesHealthcare
$3.90USDdown -0.04 (-1.02%)ClosedDelayed7:41 AM
Price$3.90-0.04 (-1.02%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5171251003
- CUSIP
- 517125100
Company
- Employees
- 71
- Headquarters
- Bala Cynwyd, United States
- Website
- https://www.larimartx.com
- CEO
- Dr. Carole S. Ben-Maimon M.D.
Market
- Shares outstanding
- 103.9M
- Market cap
- $405.14M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $405.14M
- EPS LTM
- -$1.66
- P/E LTM
- -1.85
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$172.61M-72.98%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$156.08M-68.57%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.